Erfaring
2023-: Speciallæge, Hudlæge på de lukkede højsikring-institutioner under Kriminalforsorgen
2022-: Speciallæge, Overlæge i hudsygdomme, Capio Privathospital, Århus, Odense, Aalborg og Viborg
2017-2022: Reservelæge, Hoveduddannelse, Dermatologi, Dermatologisk afd., AUH-OUH-AUH
2016-2017: Post.Doc., Dermatologisk afd., Aarhus Universitetshospital
2016: Reservelæge, I-stilling, Dermatologi, Dermatologisk afd., Aarhus Universitetshospital
2014: Gæsteforsker, Dept. of Experimental Dermatology, Radboud UMC, Holland
2013-2016: PhD-studerende, Klinisk Medicin - Dermatologisk afd., Aarhus Universitet
2012-2013: Reservelæge, I-stilling, Dermatologi, Dermatologisk afd., Aarhus Universitetshospital
2012: Reservelæge, I-stilling, Reumatologi, Medicinsk afd., Regionshospitalet Silkeborg
2012: Reservelæge, I-stilling, Intern Medicin, Medicinsk afd., Regionshospitalet Randers
2011-2012: Reservelæge, KBU, Almen praksis, Hinneruplægerne, Hinnerup
2011: Reservelæge, KBU, Ortopædkirurgisk afd. O, Regionshospitalet Randers
2008: Gæsteforsker, Dept. of Intensive Care Medicine, UZ Leuven, Belgien
Øvrig information
Faglige medlemskaber
2019-: Medlem, Dansk Dermatologisk Selskab (DDS)
2018-: Medlem, The International Eczema Council (IEC)
2017-: Medlem, International Society of Atopic Dermatitis (ISAD)
2013-: Medlem, European Society for Dermatological Research (ESDR)
2013-: Medlem, European Academy of Dermatology and Venereology (EADV)
2011-: Medlem, Society of Junior Dermatologists (FYD)
2011-: Medlem, Danish Medical Association (DMA)
2012-2015: Repræsentant i Lægeetisk Nævn
Publikationer
PUBLIKATION (21), 32 co-authers. U Nygaard, European guideline (EuroGuiDerm) on atopic eczema: Living Update, JEADV, 2025
PUBLIKATION (20), 31 co-authers. U Nygaard, First Update of the Living European Guideline (EuroGuiDerm) on Atopic Eczema, JEADV, 2023
PUBLIKATION (19), 26 co-authers. U Nygaard, European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations, JEADV, 2022
PUBLIKATION (18), 26 co-authers. U Nygaard, European guideline (EuroGuiDerm) on atopic eczema – part I: systemic therapy, JEADV, 2022
PUBLIKATION (17), JS Elsner, M Carlsson, JK Stougaard, U Nygaard, The OX40 Axis is Associated with Both Systemic and Local Involvement in Atopic Dermatitis. Acta Derm Venereol, 2020
PUBLIKATION (16), U Nygaard, C Vestergaard, M Deleuran, Emerging treatment options in atopic dermatitis - systemic therapies. Dermatol, 2018
PUBLIKATION (15), U Nygaard, M Deleuran, C Vestergaard, Emerging treatment options in atopic dermatitis - topical therapies. Dermatol, 2018
PUBLIKATION (14), JRI Chalmers, KSI Thomas, C Apfelbacher, Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). Br J Dermatol. 2018
PUBLIKATION (13), U Nygaard, J L Riis, M Deleuran, C Vestergaard, Attention-Deficit/Hyperactivity Disorder in Atopic Dermatitis: An Appraisal of the Current Literature. Pediatr Allergy Immunol Pulmonol, 2016
PUBLIKATION (12), U Nygaard, E H van den Bogaard, H Niehues, M Hvid, M Deleuran, C Johansen, C Vestergaard, The ”Alarmins” HMBG1 and IL-33 Downregulate Structural Skin Barrier Proteins and Impair Epidermal Growth. Acta Derm Venereol, 2016
PUBLIKATION (11), U Nygaard, M Hvid, C Johansen, M Buchner, R Fölster-Holst, M Deleuran, C Vestergaard, TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis. JEADV, 2016
PUBLIKATION (10), U Nygaard, C Vestergaard, C Johansen, M Deleuran, M Hvid, Measuring serum concentrations of interleukin-33 in atopic dermatitis is associated with potential false positive results. SpringerPlus, 2016
PUBLIKATION (9), H F Bungum*, U Nygaard*, C Vestergaard, P M Martensen,U B Knudsen, Increased IL-25 levels in the peritoneal fluid of patients with endometriosis. Journal of Reproductive Immunology, 2016 *Joint first authorship
PUBLIKATION (8), LA Kolstrup, KU Koopmann, U Nygaard, RH Nygaard, P Agger, Injuries during football tournaments in 45,000 children and adolescents. Eur J Sport Sci, 2016
PUBLIKATION (7), U Nygaard, H Niehues, G Rikken, D R Olthuis, J Schalkwijk, E H van den Bogaard, Antibiotics in cell culture: friend or foe? Suppression of keratinocyte growth and differentiation in monolayer cultures and 3D skin models. Experimental Dermatology, 2015
PUBLIKATION (6), U Nygaard, S Dalager, E Spaun, L Hedelund, Large eccrine angiomatous hamartoma: a novel clinical presentation of disease. Journal of Dermatological Case Reports, 2015
PUBLIKATION (5), U Nygaard, C Vestergaard, M Deleuran, Systemic Treatment of Severe Atopic Dermatitis in Children and Adults. Current Treatment Options in Allergy, 2014
PUBLIKATION (4), U Nygaard, H H Kralund, M Sommerlund, Allergic contact dermatitis induced by textile necklace. Case Rep Dermatol, 2013
PUBLIKATION (3), U Nygaard, C Vestergaard, U Koppelhus, Remitting Seronegative Symmetrical Synovitis with Pitting Oedema (RS3PE) of Hands and Feet in an 83-year-old Man. Acta Derm Venereol, 2013
PUBLIKATION (2), C Sølling, A T Christensen, U Nygaard, S Krag, J Frøkiaer, L Wogensen, J Krog, E Tønnesen. Erythropoietin does not attenuate renal dysfunction or inflammation in a porcine model of endotoxemia, Acta Anaesthesiologica Scandinavica, 2011
PUBLIKATION (1), C Sølling, U Nygaard, A T Christensen, L Wogensen, J Krog, E Tønnsen. Lymphocyte apoptosis is resistant to erythropoietin in porcine endotoxemia, Acta Pathologica, Microbiologica et Immunologica Scandinavica, 2011